Investigation of Impairments in Body Functions and Structures, Activities and Participation Restrictions in COPD
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Nov 20, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
To investigate the impairments in body functions and structures, activities and participation restrictions according to the International Classification of Functioning, Disability and Health (ICF) framework in patients with COPD, fifty patients with COPD will be included.
The Modified Medical Research Council Dyspnea (MMRC) scale and Six-Minute Walking Test (6MWT) will be used for evaluating the how dyspnea limits the patients' daily activities and functional capacity, respectively. Isometric muscle strength will be measured with a handheld dynamometer of quadriceps femoris. Fear of fallin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. stable disease (no severe exacerbations in the prior 3 months)
- • 2. ability to walk independently
- • 3. ability to read and write in Turkish
- • 4. able to follow simple instructions
- • 5. no pathology in visual ability and hearing
- Exclusion Criteria:
- • 1. a history of specific balance problems (i.e., diagnosed vestibular or neurological disorder)
- • 2. severe musculoskeletal, neurological or cardiovascular disorders that limit mobility
- • 3. use of medication(s) that may increase the risk of falls
- • 4. participate in pulmonary rehabilitation in the lasts six months
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Istanbul, Fatih/İstanbul, Turkey
Patients applied
Trial Officials
Tansu Birinci, PT, PhD
Principal Investigator
Istanbul University - Cerrahpasa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials